PDS Biotechnology Corp <PDSB.OQ> expected to post a loss of 23 cents a share - Earnings Preview
PDS Biotechnology Corp PDSB.OQ PDSB.O is expected to show no change in quarterly revenue when it reports results on August 13 for the period ending June 30 2025
LSEG's mean analyst estimate for PDS Biotechnology Corp is for a loss of 23 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for PDS Biotechnology Corp is $5.00, about 77.8% above its last closing price of $1.11
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.24 | -0.25 | -0.21 | Beat | 14.9 |
Dec. 31 2025 | -0.28 | -0.21 | Beat | 24.1 | |
Sep. 30 2024 | -0.27 | -0.28 | -0.29 | Missed | -4.2 |
Jun. 30 2024 | -0.33 | -0.34 | -0.23 | Beat | 32 |
Mar. 31 2024 | -0.37 | -0.37 | -0.30 | Beat | 18.2 |
Dec. 31 2023 | -0.60 | -0.44 | -0.35 | Beat | 20.2 |
Sep. 30 2023 | -0.44 | -0.45 | -0.35 | Beat | 21.5 |
Jun. 30 2023 | -0.35 | -0.35 | -0.37 | Missed | -6.6 |
This summary was machine generated August 11 at 13:00 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
Investing in Healthcare Stocks
TradingKey - After a year of underperformance, the health care sector is emerging as one of the most interesting places for long-term investors looking for a mixture of resilience and innovation. The health care stocks trailed broader indexes in 2024 as money poured into AI, technology...
China July Inflation Commentary: CPI Exceeds Expectations
TradingKey - On 9 August 2025, China's National Bureau of Statistics released inflation data for July. The Consumer Price Index (CPI) rose by 0.4% month-on-month, reversing the previous month's 0.1% decline, while remaining unchanged year-on-year. Core CPI increased by 0.8% year-on-year.
U.S. CPI Preview: Bullish Outlook for U.S. Stocks Continues
TradingKey - On 12 August 2025, the U.S. will release its July CPI data. Market consensus forecasts a year-over-year headline CPI increase of 2.8% and a core CPI rise of 3%, both up 0.1 percentage points from June. We align with these widely held market expectations. Breaking it down by category...
CoreWeave Faces Make-or-Break Q2: Can Its AI Growth Momentum Hold?
TradingKey - CoreWeave, Inc. (NASDAQ: CRWV) will report its Q2 FY2025 earnings on Tuesday, August 12, 2025, after the U.S. market closes. The earnings call is scheduled for 5:00 p.m. Eastern Time. Since its IPO in March 2025 at $40 per share, CoreWeave has experienced significant volatility.
Ethereum Price Prediction: Will ETH Extend the Rally? What’s the Future Trend?
Ethereum's impressive 2025 rally has been largely fueled by inflows from spot ETFs and a surge in institutional holdings, signaling growing confidence in its role as a core asset in the crypto market. However, to officially confirm the start of a new bull cycle, ETH must break above the critical $4,
